Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Alzheimer's disease: The strength of association of costs with different measures of disease severity
Authors
J. Mauskopf
J. Racketa
E. Sherrill
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 8/2010
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-010-0312-6

Other articles of this Issue 8/2010

The journal of nutrition, health & aging 8/2010 Go to the issue

Editorial

Editorial

JNHA: Nutrition

Influence of the consumption of fruits and vegetables on the nutritional status of a group of institutionalized elderly persons in the Madrid region

JNHA: Geriatric Science

An urgent need to improve life conditions of seniors

Circulating TNF Alpha Receptor Levels

Circulating TNF alpha receptor levels identify older adults who fail to regain weight after acute weight loss

Novel Approaches to Incorporating Pharmacoeconomic

Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease

Malnutrition in Elderly Rehabilitation Patients

Older rehabilitation patients are at high risk of malnutrition: Evidence from a large Australian database

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits